Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2020 | 04-2019 | 04-2018 | 04-2017 | 04-2016 | |
| Sales | 32,123 | 27,067 | 20,241 | 15,411 | 11,182 |
| Cost of Goods | 17,000 | 14,265 | 10,553 | 9,703 | 8,686 |
| Gross Profit | 15,123 | 12,802 | 9,688 | 5,708 | 2,496 |
| Operating Expenses | 17,044 | 12,797 | 11,595 | 13,220 | 13,498 |
| Operating Income | -1,921 | 270 | -1,354 | -6,809 | -10,316 |
| Other Income | -42 | -39 | -89 | -56 | -38 |
| Pre-tax Income | -1,963 | 231 | -1,443 | -6,865 | -10,354 |
| Income Tax | 130 | 103 | 33 | 19 | 92 |
| Net Income Continuous | -2,093 | 128 | -1,476 | -6,884 | -10,446 |
| Net Income | $-2,093 | $128 | $-1,476 | $-6,884 | $-10,446 |
| EPS Basic Total Ops | -0.18 | 0.01 | -0.13 | -0.64 | -1.20 |
| EPS Basic Continuous Ops | -0.18 | 0.01 | -0.13 | -0.64 | -1.20 |
| EPS Diluted Total Ops | -0.18 | 0.01 | -0.13 | -0.64 | -1.20 |
| EPS Diluted Continuous Ops | -0.18 | 0.01 | -0.13 | -0.64 | -1.20 |
| EPS Diluted Before Non-Recurring Items | -0.17 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-761 | $876 | $-994 | $-6,641 | $-10,160 |